Search

Author/Creator Stilwill, Joseph

1. A Randomized, Double‐Blinded, Phase II Trial of Carboplatin and Pemetrexed with or without Apatorsen (OGX‐427) in Patients with Previously Untreated Stage IV Non‐Squamous‐Non‐Small‐Cell Lung Cancer: The SPRUCE Trial. (16th August 2019)

Authors:
Spigel, David R.; Shipley, Dianna L.; Waterhouse, David M.; Jones, Suzanne F.; Ward, Patrick J.; Shih, Kent C.; Hemphill, Brian; McCleod, Michael; Whorf, Robert C.; Page, Ray D.; Stilwill, Joseph; Mekhail, Tarek; Jacobs, Cindy; Burris, Howard A.; Hainsworth, John D.
Journal:
Oncologist
Issue:
Volume 24:Number 12(2019)
Page Start:
e1409
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. Durvalumab plus platinum–etoposide versus platinum–etoposide in first-line treatment of extensive-stage small-cell lung cancer (CASPIAN): a randomised, controlled, open-label, phase 3 trial. Issue 10212 (23rd November 2019)

Authors:
Paz-Ares, Luis; Dvorkin, Mikhail; Chen, Yuanbin; Reinmuth, Niels; Hotta, Katsuyuki; Trukhin, Dmytro; Statsenko, Galina; Hochmair, Maximilian J; Özgüroğlu, Mustafa; Ji, Jun Ho; Voitko, Oleksandr; Poltoratskiy, Artem; Ponce, Santiago; Verderame, Francesco; Havel, Libor; Bondarenko, Igor; Kazarnowic...
Journal:
Lancet
Issue:
Volume 394:Issue 10212(2019)
Page Start:
1929
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

3. Durvalumab, with or without tremelimumab, plus platinum–etoposide versus platinum–etoposide alone in first-line treatment of extensive-stage small-cell lung cancer (CASPIAN): updated results from a randomised, controlled, open-label, phase 3 trial. Issue 1 (January 2021)

Authors:
Goldman, Jonathan W; Dvorkin, Mikhail; Chen, Yuanbin; Reinmuth, Niels; Hotta, Katsuyuki; Trukhin, Dmytro; Statsenko, Galina; Hochmair, Maximilian J; Özgüroğlu, Mustafa; Ji, Jun Ho; Garassino, Marina Chiara; Voitko, Oleksandr; Poltoratskiy, Artem; Ponce, Santiago; Verderame, Francesco; Havel, Libo...
Journal:
Lancet oncology
Issue:
Volume 22:Issue 1(2021)
Page Start:
51
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗